Cite
HARVARD Citation
Chan, A. et al. (2022). Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia. Asia-Pacific journal of clinical oncology. 18 (3), pp. 201-208. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, A. et al. (2022). Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia. Asia-Pacific journal of clinical oncology. 18 (3), pp. 201-208. [Online].